After pulmonary delivery, DNase‐I/HSA NMs effectively block cf‐mtDNA/TLR9‐mediated alveolar macrophage activation by efficiently scavenging cf‐mtDNA in the pulmonary microenvironment, thereby alleviating sepsis‐associated acute lung injury. This evidence concerns the gene ALB and Sepsis.